XML 90 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Revision of Previously Issued Consolidated Financial Statements - Consolidated Statements of Equity (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     $ 7,508       $ 8,457 $ 7,508 $ 8,457 $ 7,508 $ 8,457 $ 7,508 $ 8,457 $ 5,543
Net loss available to common shareholders $ (65) $ (10) 51 $ (105) $ (108) $ (206) (64) 41 (271) (24) (378) (78) (483) (574)
Stock-based compensation                       58 66 47
Balance at end of period       7,508               7,289 7,508 8,457
Additional Paid-in Capital                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     8,696       8,650 8,696 8,650 8,696 8,650 8,696 8,650 5,637
Net loss available to common shareholders                         0 0
Stock-based compensation                       58 66 47
Balance at end of period       8,696               8,738 8,696 8,650
Retained Earnings (Accumulated Deficit)                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     (979)       (496) (979) (496) (979) (496) (979) (496) 79
Net loss available to common shareholders                       (78) (483) (574)
Stock-based compensation                           0
Balance at end of period       (979)               (1,057) (979) (496)
As Reported                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     7,538         7,538   7,538   7,538    
Net loss available to common shareholders (49) (22) 48 (97) (104) (210) (61) 26 (271) (23) (375)   (472) (560)
Balance at end of period       7,538                 7,538  
As Reported | Additional Paid-in Capital                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     8,696       8,650 8,696 8,650 8,696 8,650 8,696 8,650 5,636
Net loss available to common shareholders                         0 0
Stock-based compensation                           48
Balance at end of period       8,696                 8,696 8,650
As Reported | Retained Earnings (Accumulated Deficit)                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     (949)       (477) (949) (477) (949) (477) (949) (477) 84
Net loss available to common shareholders                         (472) (560)
Stock-based compensation                           0
Balance at end of period       (949)                 (949) (477)
Revisions                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     (30)         (30)   (30)   (30)    
Net loss available to common shareholders $ (16) $ 12 3 (8) $ (4) $ 4 (3) 15 0 (1) (3)   (11) (14)
Balance at end of period       (30)                 (30)  
Revisions | Additional Paid-in Capital                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     0       0 0 0 0 0 0 0 1
Net loss available to common shareholders                         0 0
Stock-based compensation                           (1)
Balance at end of period       0                 0 0
Revisions | Retained Earnings (Accumulated Deficit)                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Balance at beginning of period     $ (30)       $ (19) $ (30) $ (19) $ (30) $ (19) $ (30) (19) (5)
Net loss available to common shareholders                         (11) (14)
Stock-based compensation                           0
Balance at end of period       $ (30)                 $ (30) $ (19)